Want to see JP:4552 full AI Analyst Report?
JCR Pharmaceuticals Co., Ltd. (4552) Q2 2026 Earnings Report
JP:4552 Q2 2026 EPS Results
- Actual EPS
- -JPY 16.03
- Consensus EPS
- JPY 0.17
- Beat/Miss
- Missed by -JPY 16.20
- One Year Ago EPS
- JPY 18.51
JP:4552 Q2 2026 Revenue Results
- Actual Revenue
- JPY 10.27B
- Expected Revenue
- JPY 12.62B
- Beat/Miss
- Missed by -JPY 2.34B
- YoY Revenue Growth
- -19.69%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 10/29/2026
- Time
- TBA
- Conference Call
- Thursday, October 29, 2026
JP:4552 Upcoming Earnings
JCR Pharmaceuticals Co., Ltd.'s next earnings date is estimated for January 28, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
JP:4552 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 28, 2027 | 2026 (Q3) | -13.83- | 0.27 | ― | ― |
| Oct 29, 2026 | 2026 (Q2) | 0.17-16.03 | 18.51 | -186.60% (-34.54) | |
| Jul 30, 2026 | 2026 (Q1) | -11.27-15.64 | -4.48 | -249.11% (-11.16) | |
| May 13, 2026 | 2025 (Q4) | -6.633.57 | -33.8 | 110.56% (+37.37) | |
| Jan 28, 2026 | 2025 (Q3) | -1.070.27 | 0.9 | -70.00% (-0.63) | |
| Oct 30, 2025 | 2025 (Q2) | 20.3918.51 | -7.14 | 359.24% (+25.65) | |
| Jul 30, 2025 | 2025 (Q1) | 4.36-4.48 | 1.61 | -378.26% (-6.09) | |
| May 13, 2025 | 2024 (Q4) | -53.70-33.80 | 2.78 | -1315.83% (-36.58) | |
| Jan 31, 2025 | 2024 (Q3) | 11.180.90 | -0.75 | 220.00% (+1.65) | |
| Oct 30, 2024 | 2024 (Q2) | 13.72-7.14 | 29.19 | -124.46% (-36.33) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
